Oncology, CNS Agents May Dominate 2006 NME Approvals; 2005 Total Is 18
The first half of 2006 could bring at least five novel oncologic approvals, including three for hematologic cancers
The first half of 2006 could bring at least five novel oncologic approvals, including three for hematologic cancers